These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36045608)

  • 21. FoxO3a contributes to the reprogramming process and the differentiation of induced pluripotent stem cells.
    Wang Y; Tian C; Zheng JC
    Stem Cells Dev; 2013 Nov; 22(22):2954-63. PubMed ID: 23815557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Current progress and application prospects of induced pluripotent stem cells].
    Qin T; Miao XY
    Yi Chuan; 2010 Dec; 32(12):1205-14. PubMed ID: 21513145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concise review: reprogramming strategies for cardiovascular regenerative medicine: from induced pluripotent stem cells to direct reprogramming.
    Budniatzky I; Gepstein L
    Stem Cells Transl Med; 2014 Apr; 3(4):448-57. PubMed ID: 24591731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reprogramming of somatic cells.
    Rajasingh J
    Prog Mol Biol Transl Sci; 2012; 111():51-82. PubMed ID: 22917226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Linking incomplete reprogramming to the improved pluripotency of murine embryonal carcinoma cell-derived pluripotent stem cells.
    Chang G; Miao YL; Zhang Y; Liu S; Kou Z; Ding J; Chen DY; Sun QY; Gao S
    PLoS One; 2010 Apr; 5(4):e10320. PubMed ID: 20436676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induced pluripotent stem cells and their potential for basic and clinical sciences.
    Ye L; Swingen C; Zhang J
    Curr Cardiol Rev; 2013 Feb; 9(1):63-72. PubMed ID: 22935022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emerging methods for preparing iPS cells.
    Miyazaki S; Yamamoto H; Miyoshi N; Takahashi H; Suzuki Y; Haraguchi N; Ishii H; Doki Y; Mori M
    Jpn J Clin Oncol; 2012 Sep; 42(9):773-9. PubMed ID: 22826352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single transcription factor reprogramming of hair follicle dermal papilla cells to induced pluripotent stem cells.
    Tsai SY; Bouwman BA; Ang YS; Kim SJ; Lee DF; Lemischka IR; Rendl M
    Stem Cells; 2011 Jun; 29(6):964-71. PubMed ID: 21563278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells.
    Martinez-Fernandez A; Nelson TJ; Ikeda Y; Terzic A
    J Cardiovasc Transl Res; 2010 Feb; 3(1):13-23. PubMed ID: 20221419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reprogramming of somatic cells: iPS and iN cells.
    Broccoli V
    Prog Brain Res; 2017; 230():53-68. PubMed ID: 28552235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Viable fertile mice generated from fully pluripotent iPS cells derived from adult somatic cells.
    Zhao XY; Li W; Lv Z; Liu L; Tong M; Hai T; Hao J; Wang X; Wang L; Zeng F; Zhou Q
    Stem Cell Rev Rep; 2010 Sep; 6(3):390-7. PubMed ID: 20549390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunotherapy with pluripotent stem cell-derived dendritic cells.
    Senju S; Matsunaga Y; Fukushima S; Hirata S; Motomura Y; Fukuma D; Matsuyoshi H; Nishimura Y
    Semin Immunopathol; 2011 Nov; 33(6):603-12. PubMed ID: 21461992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accelerated generation of human induced pluripotent stem cells with retroviral transduction and chemical inhibitors under physiological hypoxia.
    Shimada H; Hashimoto Y; Nakada A; Shigeno K; Nakamura T
    Biochem Biophys Res Commun; 2012 Jan; 417(2):659-64. PubMed ID: 22172948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of pig induced pluripotent stem cells using an extended pluripotent stem cell culture system.
    Xu J; Yu L; Guo J; Xiang J; Zheng Z; Gao D; Shi B; Hao H; Jiao D; Zhong L; Wang Y; Wu J; Wei H; Han J
    Stem Cell Res Ther; 2019 Jun; 10(1):193. PubMed ID: 31248457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nuclear reprogramming strategy modulates differentiation potential of induced pluripotent stem cells.
    Martinez-Fernandez A; Nelson TJ; Terzic A
    J Cardiovasc Transl Res; 2011 Apr; 4(2):131-7. PubMed ID: 21207217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retention of Somatic Memory Associated with Cell Identity, Age and Metabolism in Induced Pluripotent Stem (iPS) Cells Reprogramming.
    Khoo TS; Jamal R; Abdul Ghani NA; Alauddin H; Hussin NH; Abdul Murad NA
    Stem Cell Rev Rep; 2020 Apr; 16(2):251-261. PubMed ID: 32016780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances and applications of induced pluripotent stem cells.
    Pietronave S; Prat M
    Can J Physiol Pharmacol; 2012 Mar; 90(3):317-25. PubMed ID: 22364544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimal ratio of transcription factors for somatic cell reprogramming.
    Nagamatsu G; Saito S; Kosaka T; Takubo K; Kinoshita T; Oya M; Horimoto K; Suda T
    J Biol Chem; 2012 Oct; 287(43):36273-82. PubMed ID: 22955270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human-induced pluripotent stem cells: in quest of clinical applications.
    Madonna R
    Mol Biotechnol; 2012 Oct; 52(2):193-203. PubMed ID: 22302314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induced pluripotent stem (iPS) cells from human fetal stem cells.
    Guillot PV
    Best Pract Res Clin Obstet Gynaecol; 2016 Feb; 31():112-20. PubMed ID: 26427551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.